Status:
COMPLETED
Flomax Study for Floppy Iris Syndrome
Lead Sponsor:
University of Michigan
Conditions:
Floppy Iris Syndrome
Eligibility:
MALE
18+ years
Brief Summary
Some men who have a history of use of Tamsulosin (Flomax) are at risk for a condition called Intraoperative Floppy Iris Syndrome that can develop during otherwise routine cataract surgery. It is not f...
Detailed Description
Male patients scheduled for cataract surgery who are currently taking tamsulosin will be recruited into the study. Age-matched male control patients undergoing cataract surgery, without a history of u...
Eligibility Criteria
Inclusion
- Male
- 18 years or older
- Scheduled for Cataract Surgery
- Current or Past use of Tamsulosin (flomax)
- Blue colored iris
- For controls, no history of Flomax
Exclusion
- Females
- Diabetes
- Glaucoma
- Use of medicated eye drops
- Trauma or prior surgery to the eye
- Black or brown iris
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT01252472
Start Date
June 1 2010
End Date
December 1 2013
Last Update
April 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kellogg Eye Center, 1000 Wall Street
Ann Arbor, Michigan, United States, 48105